Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
672.10
|
|
670.00
|
657.00
|
674.90
|
674.50
|
672.10
|
665.28
|
104 588 000.00
|
14 781.00
|
|
|
663.90
|
658.65
|
672.00
|
670.05
|
669.60
|
666.33
|
91 396 000.00
|
15 706.00
|
660.45
|
|
654.30
|
645.00
|
664.50
|
662.00
|
660.45
|
652.17
|
110 371 000.00
|
11 123.00
|
|
650.90
|
659.70
|
638.05
|
662.00
|
646.55
|
650.90
|
645.88
|
250 242 000.00
|
11 481.00
|
|
659.70
|
648.00
|
648.00
|
664.50
|
655.00
|
659.70
|
659.66
|
80 568 000.00
|
16 557.00
|
|
646.80
|
640.00
|
635.75
|
649.85
|
648.00
|
646.80
|
644.13
|
175 064 000.00
|
6 646.00
|
|
641.50
|
645.45
|
635.15
|
649.00
|
642.10
|
641.50
|
644.39
|
30 795 000.00
|
6 348.00
|
|
|
637.45
|
627.45
|
649.70
|
645.00
|
645.45
|
638.97
|
45 098 000.00
|
11 155.00
|
|
637.45
|
647.95
|
632.25
|
651.05
|
633.55
|
637.45
|
639.98
|
62 316 000.00
|
14 773.00
|
644.55
|
|
638.85
|
632.25
|
649.90
|
641.60
|
644.55
|
641.72
|
45 304 000.00
|
11 287.00
|
Период |
---|
2021, регулярные |
2021, Внеплановые |
2021, регулярные |
2021, Внеплановые |
2021, регулярные |
2020, регулярные |
2020, регулярные |
2018, регулярные |
2017, регулярные |
2016, регулярные |
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
---|---|---|
08.09.2022
|
12.09.2022 |
1 INR |
08.09.2022
|
12.09.2022 |
5 INR |
12.05.2022
|
17.05.2022 |
1 INR |
14.02.2022
|
16.02.2022 |
2 INR |
14.02.2022
|
16.02.2022 |
1 INR |
12.08.2021
|
17.08.2021 |
1 INR |
16.02.2021
|
18.02.2021 |
1 INR |
13.02.2019
|
15.02.2019 |
1.5 INR |
05.02.2018
|
07.02.2018 |
1.5 INR |
07.02.2017
|
09.02.2017 |
1 INR |
Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company incorporated on 6th November 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates Active Pharmaceutical Ingredients (API) Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical biotechnology and chemical companies.